Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCOGNITO: Tiotropium and Olodaterol in Neutrophilic COPD
NCT03152149Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Jun 2017
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tiotropium, olodaterol in chronic obstructive pulmonary disease (COPD), sponsored by University of Dundee. Started Jun 2017; status: completed.
02
Drugs
tiotropiumolodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03152149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03152149.